Effective treatment of experimental autoimmune neuritis with Fc fragment of human immunoglobulin

Journal of Neuroimmunology

Volumn 186, Issue 1-2, 2007, Pages 133-140

  Lin, Hsin Hsin ^a   Wang, Min Xia ^a,b   Spies, Judith M ^a,b   Pollard, John D ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Experimental autoimmune neuritis (EAN); Fc fragment; Inflammatory demyelinating neuropathies; IV immunoglobulin (IVIg)

Indexed keywords

ALBUMIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; PENTOBARBITAL;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; COW; DEMYELINATING NEUROPATHY; DRUG EFFICACY; ELECTROPHYSIOLOGY; FEMALE; INFLAMMATION; MOUSE; MUSCLE ACTION POTENTIAL; MUSCLE FUNCTION; NERVE ROOT; NEURITIS; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; SOMATOSENSORY CORTEX; TREATMENT OUTCOME;

ACTION POTENTIALS; ANIMALS; BODY WEIGHT; DISEASE MODELS, ANIMAL; ELECTROMYOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOLOGIC FACTORS; MUSCLE, SKELETAL; NEURAL CONDUCTION; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS; RATS, INBRED LEW; REACTION TIME; SCIATIC NERVE; SPINAL NERVE ROOTS; TIME FACTORS;

EID: 34248659389     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.03.016     Document Type: Article

References (39)

1. Baldridge J.R., and Buchmeier M.J. Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection. J. Virol. 66 (1992) 4252-4257
2. Basta M., and Dalakas M.C. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments. J. Clin. Invest. 94 (1994) 1729-1735
3. Buchwald B., Ahangari R., Weishaupt A., and Toyka K.V. Intravenous immunoglobulins neutralize blocking antibodies in Guillain-Barré syndrome. Ann. Neurol. 51 (2002) 673-680
4. Créange A., Gregson N.A., and Hughes R.A. Intravenous immunoglobulin modulates lymphocyte CD54 and monocyte FcgammaRII expression in patients with chronic inflammatory neuropathies. J. Neuroimmunol. 135 (2003) 91-95
5. Dalakas M.C. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Pharmacol. Ther. 102 (2004) 177-193
6. Fujioka T., Purev E., and Rostami A. Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis. J. Neuroimmunol. 97 (1999) 51-59
7. Goding J.W. Use of staphylococcal protein A as an immunological reagent. J. Immunol. Methods 20 (1978) 241-253
8. Hartung H.P., and Toyka K.V. T-cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome. Ann. Neurol. 27 (1990) S57-S63 (Suppl)
9. Harvey G.K., and Pollard J.D. Patterns of conduction impairment in experimental allergic neuritis. An electrophysiological and histological study. J. Neurol. Neurosurg. Psychiatry 55 (1992) 909-915
10. Heininger K., Stoll G., Linington C., Toyka K.V., and Wekerle H. Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines. Ann. Neurol. 19 (1986) 44-49
11. Heininger K., Schäfer B., Hartung H.P., Fierz W., Linington C., and Toyka K.V. The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line. Ann. Neurol. 23 (1988) 326-331
12. Hughes R.A., Raphaël J.C., Swan A.V., and Doorn P.A. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst. Rev. (2004) CD002063
13. Jacobs B.C., O'Hanlon G.M., Bullens R.W., Veitch J., Plomp J.J., and Willison H.J. Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. Brain 126 (2003) 2220-2234
14. Kaveri S., Vassilev T., Hurez V., Lengagne R., Lefranc C., Cot S., Pouletty P., Glotz D., and Kazatchkine M.D. Antibodies to a conserved region of HLA class I molecules, capable of modulating CD8 T cell-mediated function, are present in pooled normal immunoglobulin for therapeutic use. J. Clin. Invest. 97 (1996) 865-869
15. Kiefer R., Kieseier B.C., Stoll G., and Hartung H.P. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog. Neurobiol. 64 (2001) 109-127
16. Kieseier B.C., Krivacic K., Jung S., Pischel H., Toyka K.V., Ransohoff R.M., and Hartung H.P. Sequential expression of chemokines in experimental autoimmune neuritis. J. Neuroimmunol. 110 (2000) 121-129
17. Kieseier B.C., Kiefer R., Gold R., Hemmer B., Willison H.J., and Hartung H.P. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30 (2004) 131-156
18. Liang M., Chu Y.K., and Schmaljohn C. Bacterial expression of neutralizing mouse monoclonal antibody Fab fragments to Hantaan virus. Virology 217 (1996) 262-271
19. Lin H.H., Spies J.M., Lu J.L., and Pollard J.D. Effective treatment of experimental autoimmune neuritis with human immunoglobulin. J. Neurol. Sci. (2007) 10.1016/j.jns.2007.02.017
20. Ling Z.D., Ziltener H.J., Webb B.T., and Matheson D.S. Aggregated immunoglobulin and Fc fragment of IgG induce IL-6 release from human monocytes. Cell. Immunol. 129 (1990) 95-103
21. Linington C., Izumo S., Suzuki M., Uyemura K., Meyermann R., and Wekerle H. A permanent rat T cell line that mediates experimental allergic neuritis in the Lewis rat in vivo. J. Immunol. 133 (1984) 1946-1950
22. Linington C., Lassmann H., Ozawa K., Kosin S., and Mongan L. Cell adhesion molecules of the immunoglobulin supergene family as tissue-specific autoantigens: induction of experimental allergic neuritis (EAN) by P0 protein-specific T cell lines. Eur. J. Immunol. 22 (1992) 1813-1817
23. Mäurer M., Toyka K.V., and Gold R. Immune mechanisms in acquired demyelinating neuropathies: lessons from animal models. Neuromuscul. Disord. 12 (2002) 405-414
24. Miyagi F., Horiuchi H., Nagata I., Kitahara S., Kiyoki M., Komoriya K., and Yuki N. Fc portion of intravenous immunoglobulin suppresses the induction of experimental allergic neuritis. J. Neuroimmunol. 78 (1997) 127-131
25. Norton W.T., and Poduslo S.E. Myelination in rat brain: method of myelin isolation. J. Neurochem. 21 (1973) 749-757
26. Pollard J.D., Westland K.W., Harvey G.K., Jung S., Bonner J., Spies J.M., Toyka K.V., and Hartung H.P. Activated T cells of nonneural specificity open the blood-nerve barrier to circulating antibody. Ann. Neurol. 37 (1995) 467-475
27. Samuelsson A., Towers T.L., and Ravetch J.V. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor. Science 291 (2001) 484-486
28. Schlesinger J.J., and Chapman S. Neutralizing F(ab′)2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis. J. Gen. Virol. 76 Pt 1 (1995) 217-220
29. Simon H.U., and Späth P.J. IVIG-mechanisms of action. Allergy 58 (2003) 543-552
30. Siragam V., Crow A.R., Brinc D., Song S., Freedman J., and Lazarus A.H. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells. Nat. Med. 12 (2006) 688-692
31. Spies J.M., Pollard J.D., Bonner J.G., Westland K.W., and McLeod J.G. Synergy between antibody and P2-reactive T cells in experimental allergic neuritis. J. Neuroimmunol. 57 (1995) 77-84
32. Sumner A.J., Saida K., Saida T., Silberberg D.H., and Asbury A.K. Acute conduction block associated with experimental antiserum-mediated demyelination of peripheral nerve. Ann. Neurol. 11 (1982) 469-477
33. Svenson M., Hansen M.B., and Bendtzen K. Binding of cytokines to pharmaceutically prepared human immunoglobulin. J. Clin. Invest. 92 (1993) 2533-2539
34. van Doorn P.A. Treatment of Guillain-Barre syndrome and CIDP. J. Peripher. Nerv. Syst. 10 (2005) 113-127
35. van Schaik I.N., Winer J.B., de Haan R., and Vermeulen M. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy: a systematic review. Lancet Neurol. 1 (2002) 491-498
36. Wiethölter H., and Hülser P.J. Lumbar-spinal somatosensory evoked potentials in the rat after stimulation of the tibial nerve. Exp. Neurol. 89 (1985) 24-31
37. Yu Z., and Lennon V.A. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune diseases. N. Engl. J. Med. 340 (1999) 227-228
38. Zhang G., Lopez P.H., Li C.Y., Mehta N.R., Griffin J.W., Schnaar R.L., and Sheikh K.A. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies. Brain 127 (2004) 1085-1100
39. Zhu J., Mix E., and Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome. J. Neuroimmunol. 84 (1998) 40-52